2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

909. Medical Education and Workforce Development: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Molecular Testing, Treatment Considerations, Supportive Care, Biological Therapies, Bispecific Antibody Therapy, Women’s Health, Workforce, Adverse Events, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Patient Safety, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Value, Diseases, Bleeding and Clotting, Hemoglobinopathies, Sickle Cell Disease, Lymphoid Malignancies, Lymphoid Leukemias, Myeloid Malignancies, Acute Myeloid Malignancies, ALL, Research, Fundamental Science, Translational Research, Clinical Research, Health Outcomes Research, Real-World Evidence, Survivorship, Study Population, Human, Adult, Elderly, Pediatric, Neonatal, Pregnant, Young Adult
PAPER

6366 Structured event reviews by hematology/oncology trainees - implementing change and the confidence to lead

Tara Rakiewicz, MD, Liam Heneghan, MD2, Gloria Espinosa, PharmD3, Lindsay Wilde, MD4, Adam Binder, MD5
1 Thomas Jefferson University Sidney Kimmel Comprehensive Cancer Center, Philadelphia, Pennsylvania, United States
2 Thomas Jefferson University Sidney Kimmel Comprehensive Cancer Center, Philadelphia, Pennsylvania, United States
3 Thomas Jefferson University Sidney Kimmel Comprehensive Cancer Center, Philadelphia, Pennsylvania, United States
4 Thomas Jefferson University Sidney Kimmel Comprehensive Cancer Center, Philadelphia, Pennsylvania, United States
5 Thomas Jefferson University Sidney Kimmel Comprehensive Cancer Center, Philadelphia, Pennsylvania, United States

Introduction: The Institute of Medicine’s (IOM) “To Err is Human” was a watershed report published in 1999 outlining the scope of medical error causing harm in America. This ultimately led to the IOM releasing aims for healthcare improvement two years later in 2001, which outlined various areas for systemic reform including safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity. In 2017, the Accreditation Council for Graduate Medical Education (ACGME) updated the Common Program requirements to mandate residents’ participation in interprofessional patient safety activities. A recent review suggested that standardization of Morbidity and Mortality Conference (MMC) can optimally address issues of patient safety and quality improvement (QI). As part of an ACGME program to standardize event reviews, our institution developed and implemented a uniform process for event reviews across multiple departments, including the Department of Oncology. Using this standardized format, MMC was redesigned to include structured root cause analysis and improvement tools to identify opportunities for change to prevent future events. This describes our 5-year experience, including survey results from the program’s participants.  

Methods: First year hematology/oncology fellows at Thomas Jefferson University Hospital are assigned to present an MMC based on their schedule and workload. An introductory lecture is given by a core faculty member in QI to detail the formal event review process, discuss fundamentals of the structured review, and introduce change management concepts. Events are identified through our event reporting system or faculty/trainee awareness of an event that they would like to review.  Details of the event are emailed to the reviewing fellow at least 28 days prior to their presentation date. The fellow has structured check-ins with a QI mentor weekly to discuss the case, receive guidance on the review process, and get feedback on the presentation. After the presentation, fellows are encouraged to implement at least one of the changes proposed in their presentation. If the fellow is not interested, or unable to pursue the project, a QI team will often volunteer to do so. After 5 years, surveys were sent out to all those who participated in the program to better understand their perspectives. We developed an 8-question survey to evaluate participant perceptions of their event reviews and to understand if they continued to perform event reviews, independent of the program. For questions 1 and 2, a 5-point Likert scale was used ranging from (5) lowest rating to (1) highest rating. Questions 3-8 were composed of yes/no questions.    

Results: From 2021-2026, 23 event reviews were completed. 19 of 23 followed the structured check-in format. Of the 4 deviations from these structured check-ins, 2 were because the QI mentor was unavailable and the other 2 were due to the fellow not responding to weekly check-ins. All presentations occurred as planned and had robust attendance from peers and faculty. 18 of 23 (78.3%) MMC led to quality improvement initiatives. Improvement changes ranged from improved documentation for chemotherapy safety, to workflow and process improvement changes that allowed for outpatient management of acute medical issues (i.e. hypercalcemia of malignancy and sepsis). 23 past participants from 2023-2025 were sent a survey for further evaluation; 17 responded. When asked how the program prepared to lead independent QI initiatives, 10 responded strongly positive/positive, with Likert scale between 1-2. When asked how the program prepared the participant to perform event reviews, 13 responded strongly positive/positive, with Likert scale between 1-2. Four participants had performed at least one additional event review and QI project since the program, culminating in 5 additional event reviews and 5 additional QI projects. 14 of 17 participants stated that there was adequate QI training during fellowship. 

Conclusion: Standardized MMC presentations from fellows led to 23 formal event reviews and resulted in 18 QI projects. The skills obtained from this process led to 10 additional reviews/initiatives after fellows had completed their event reviews. Most surveyed participants (76%) agreed that they were prepared to lead additional event reviews as well as QI initiatives (59%). This highlights the importance of standardization of MMC as well as continued importance of QI training in trainees. 

Tara Rakiewicz, MD: No relevant conflicts of interest to declare.